Advertisement
Screener

SUTRO BIOPHARMA, INC. (STRO) Other

SUTRO BIOPHARMA, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2022-05-09: Form 10-Q; Item Smaller reporting company; As filed No.
  • 2022-02-28: Form 10-K; Item Smaller reporting company; As filed No.
  • 2021-11-10: Form 10-Q; Item Emerging growth company; As filed Yes.
  • 2021-08-09: Form 10-Q; Item Emerging growth company; As filed Yes.
FiledFormItemAs filed
2022-05-0910-QSmaller reporting companyNo
2022-02-2810-KSmaller reporting companyNo
2021-11-1010-QEmerging growth companyYes
2021-08-0910-QEmerging growth companyYes
2021-05-0710-QEmerging growth companyYes
2021-03-1810-KEmerging growth companyYes
2021-03-1810-KWell-known seasoned issuerYes
2020-11-0510-QStock registered under Section 12(b)Common stock, $0.001 par value · STRO · Nasdaq Global Market
2020-11-0510-QEmerging growth companyYes
2020-08-0610-QStock registered under Section 12(b)Common stock, $0.001 par value · STRO · Nasdaq Global Market
2020-08-0610-QEmerging growth companyYes
2020-05-1110-QStock registered under Section 12(b)Common stock, $0.001 par value · STRO · Nasdaq Global Market
2020-05-1110-QEmerging growth companyYes
2020-03-1610-KStock registered under Section 12(b)Common stock, $0.001 par value · STRO · Nasdaq Global Market
2020-03-1610-KEmerging growth companyYes
2019-11-0810-QSmaller reporting companyNo
2019-11-0810-QEmerging growth companyYes
2019-08-1410-QSmaller reporting companyNo
2019-08-1410-QEmerging growth companyYes
2019-05-1510-QSmaller reporting companyNo
2019-05-1510-QEmerging growth companyYes
2019-04-0110-KSmaller reporting companyNo
2019-04-0110-KEmerging growth companyYes
2018-11-1410-QSmaller reporting companyNo
2018-11-1410-QEmerging growth companyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Invivyd, Inc. (IVVD)United States$0.270B-2.42
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Liminatus Pharma, Inc. (LIMN)United States$0.282B
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87